13.02.2017 13:30:00
|
Accuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017
SUNNYVALE, Calif., Feb. 13, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Kevin Waters, Senior Vice President and Chief Financial Officer, is scheduled to meet with investors one-on-one at the 2017 RBC Capital Markets Healthcare Conference in New York on Wednesday, February 22, 2017.
Attendance at the conference is by RBC Capital Markets invitation only. The investor presentation used at the conference will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors on February 22, 2017.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com
Contacts: | |
Investors: | Brian Moore, EVC Group, 310-770-0389 (bmoore@evcgroup.com) |
Doug Sherk, EVC Group, 415-652-9100 (dsherk@evcgroup.com) | |
Media: | Beth Kaplan |
Public Relations Director, Accuray | |
408-789-4426 | |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-participate-in-the-2017-rbc-capital-markets-healthcare-conference-on-february-22-2017-300406034.html
SOURCE Accuray Incorporated
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Accuray IncShsmehr Nachrichten
05.11.24 |
Ausblick: Accuray stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
13.08.24 |
Ausblick: Accuray legt Quartalsergebnis vor (finanzen.net) |